» Articles » PMID: 36837502

ACE2-Inhibitory Effects of Bromelain and Ficin in Colon Cancer Cells

Overview
Publisher MDPI
Specialty General Medicine
Date 2023 Feb 25
PMID 36837502
Authors
Affiliations
Soon will be listed here.
Abstract

: Bromelain and ficin are aqueous extracts from fruits of and plants, used widely for medical applications. Angiotensin-converting enzyme 2 (ACE2) is a homolog of ACE, degrading Ang II to angiotensin 1-7 and decreasing the cellular concentration of Ang II. : In this study, we investigated the ACE2-inhibitory, antiproliferative, and apoptosis-inducing effects of ficin and bromelain on caco-2 cells. : We found that bromelain and ficin significantly reduced the viability of human colon cancer cells with IC value concentrations of 8.8 and 4.2 mg/mL for bromelain after 24 and 48 h treatments, and 8.8 and 4.2 mg/mL for ficin after 24 and 48 h treatments, respectively. The apoptosis of the caco-2 cell line treated with bromelain was 81.04% and 56.70%, observed after 24 and 48 h. Total apoptotic proportions in caco-2 cells treated with ficin after 24 and 48 h were 83.7% and 73.0%. An amount of 1.6 mg/mL of bromelain and ficin treatments on caco-2 cells after 24 h revealed a higher decrease than that of other concentrations in the expression of ACE2 protein. : In conclusion, bromelain and ficin can dose-dependently decrease the expression of ACE2 protein in caco-2 cells.

Citing Articles

Anticancer Potential of Pineapple and its Bioactive Compound Bromelain.

Kumar D, Suchitra , Mundlia J, Yadav S, Yadav D, Aggarwal N Curr Pharm Des. 2024; 31(6):461-483.

PMID: 39279108 DOI: 10.2174/0113816128303910240713180835.


Exploring the Therapeutic Potential of Bromelain: Applications, Benefits, and Mechanisms.

Kansakar U, Trimarco V, Manzi M, Cervi E, Mone P, Santulli G Nutrients. 2024; 16(13).

PMID: 38999808 PMC: 11243481. DOI: 10.3390/nu16132060.

References
1.
Galanopoulos M, Gkeros F, Doukatas A, Karianakis G, Pontas C, Tsoukalas N . COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. 2020; 26(31):4579-4588. PMC: 7445869. DOI: 10.3748/wjg.v26.i31.4579. View

2.
Mizuiri S, Ohashi Y . ACE and ACE2 in kidney disease. World J Nephrol. 2015; 4(1):74-82. PMC: 4317630. DOI: 10.5527/wjn.v4.i1.74. View

3.
Zheng Y, Ma Y, Zhang J, Xie X . Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'. Nat Rev Cardiol. 2020; 17(5):313-314. PMC: 7104711. DOI: 10.1038/s41569-020-0369-9. View

4.
Sagar S, Rathinavel A, Lutz W, Struble L, Khurana S, Schnaubelt A . Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein. Clin Transl Med. 2021; 11(2):e281. PMC: 7811777. DOI: 10.1002/ctm2.281. View

5.
de Lencastre Novaes L, Jozala A, Lopes A, Santos-Ebinuma V, Mazzola P, Pessoa Junior A . Stability, purification, and applications of bromelain: A review. Biotechnol Prog. 2015; 32(1):5-13. DOI: 10.1002/btpr.2190. View